MyAverix Finance MyAverix Finance

BE · Other

BIOALLIANCE PHARMA (C4X)

Other

BIOALLIANCE PHARMA (C4X) is listed on BE in the Other sector. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for C4X

P/E ratio
18.00

BIOALLIANCE PHARMA (C4X) — FAQ

What is C4X's P/E ratio?

The price-to-earnings (P/E) ratio for BIOALLIANCE PHARMA (C4X) is 18.00 (data as of 2026-03-22).

Does BIOALLIANCE PHARMA pay a dividend?

Dividend yield is not available in the current snapshot for BIOALLIANCE PHARMA (C4X). Check the MyAverix Finance app for the latest dividend data.

What sector is BIOALLIANCE PHARMA in?

BIOALLIANCE PHARMA (C4X) is classified in the Other sector.

What exchange is C4X listed on?

C4X is listed on BE.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Apple Inc (APC) Microsoft Corporation (MSF)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play